Does MEDROXYPROGESTERONE Cause Malignant neoplasm progression? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Malignant neoplasm progression have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 0.1% of all adverse event reports for MEDROXYPROGESTERONE.
12
Reports of Malignant neoplasm progression with MEDROXYPROGESTERONE
0.1%
of all MEDROXYPROGESTERONE reports
5
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From MEDROXYPROGESTERONE?
Of the 12 reports, 5 (41.7%) resulted in death.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEDROXYPROGESTERONE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does MEDROXYPROGESTERONE Cause?
Meningioma (1,364)
Drug dose omission by device (510)
Device leakage (500)
Incorrect dose administered by device (410)
Drug ineffective (403)
Off label use (390)
Syringe issue (354)
Needle issue (346)
Headache (288)
Device occlusion (284)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which MEDROXYPROGESTERONE Alternatives Have Lower Malignant neoplasm progression Risk?
MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE
MEDROXYPROGESTERONE vs MEFENAMIC ACID
MEDROXYPROGESTERONE vs MEFLOQUINE
MEDROXYPROGESTERONE vs MEGESTROL
MEDROXYPROGESTERONE vs MEGLUMINE